 TRILEPTAL
|
Novartis
|
| oxcarbazepina |
Anticonvulsivo |
| 300 mg comp.x 30 | $53.837,96 | (29/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.451,24 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $15.032,22 |
|
|
|
|
| 300 mg comp.x 60 | $89.661,74 | (29/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.118,46 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $22.075,79 |
|
|
|
|
| 600 mg comp.x 30 | $103.636,94 | (29/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $16.268,40 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $64.831,20 |
|
|
|
|
| 600 mg comp.x 60 | $176.512,93 | (29/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.708,02 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $108.926,98 |
|
|
|
|
| jbe.x 100 ml | $33.621,99 | (29/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $5.277,59 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $20.354,61 AF $13.267,38 |
|
|
|
|
| |
